Gam-COVID-Vac / Gam-COVID-Vac

DRUG2 trials

Sponsors

Ministerio de Salud de Ciudad Autónoma de Buenos Aires

Conditions

COVID-19 Vaccines

Phase 2

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes

CompletedNCT04962906

Ministerio de Salud de Ciudad Autónoma de Buenos AiresCOVID-19 Vaccines

Start: 2021-07-05End: 2021-08-15Updated: 2021-08-20

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population

Ministerio de Salud de Ciudad Autónoma de Buenos AiresCOVID-19 Vaccines

Start: 2021-07-26End: 2021-09-26Target: 120Updated: 2021-07-30

Related Papers

Immunogenicity induced by the use of alternative vaccine platforms to deal with vaccine shortages in a low- to middle-income country: Results of two randomized clinical trials.

2022-02-028 citations